Neonatal jaundice ultrasound: Difference between revisions
Jump to navigation
Jump to search
Megan Merlo (talk | contribs) No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Neonatal jaundice}} | {{Neonatal jaundice}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} | ||
==Overview== | ==Overview== | ||
Ultrasonography of the liver and bile ducts is warranted in infants with laboratory or clinical signs of cholestatic disease. | |||
==Ultrasound== | ==Ultrasound== | ||
Ultrasonography of the liver and bile ducts is warranted in infants with laboratory or clinical signs of cholestatic disease. | |||
==References== | ==References== | ||
Revision as of 21:17, 2 January 2018
|
Neonatal jaundice Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neonatal jaundice ultrasound On the Web |
|
American Roentgen Ray Society Images of Neonatal jaundice ultrasound |
|
Risk calculators and risk factors for Neonatal jaundice ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Ultrasonography of the liver and bile ducts is warranted in infants with laboratory or clinical signs of cholestatic disease.
Ultrasound
Ultrasonography of the liver and bile ducts is warranted in infants with laboratory or clinical signs of cholestatic disease.